Connect Biopharma Holdings Limited — Income Charts
7 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$698K
$0
R&D↑+80.9% +$5M
$11M
D&A↑+14.6% +$23K
$181K
Operating Income↓-27.7% -$4M
$-18M
EBITDA↑+14.6% +$23K
$181K
Other Income/Expense↓-47.6% -$489K
$538K
Pretax Income↓-33.7% -$4M
$-17M
Tax Provision↓-74.5% -$79K
$27K
Net Income↓-33.6% -$4M
$-17M
Operating Margin↓-109345.4pts
-110481.3%
Net Margin↓-106443.7pts
-107500.0%
Effective Tax Rate↑+0.1pts
-0.4%
ETR (Continuing Operations)↑+1.2pts
-0.3%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
0.0%
ETR Foreign Differential (pp)
-32.6%
Operating Lease Cost↑+71.3% +$62K
$149K
Revenue YoY Variation
-100.0%
Income YoY Variation
-27.7%
Revenue QoQ Variation↓-57.3pts
-100.0%
Income QoQ Variation↑+169.8pts
-31.7%